Eledon Pharmaceuticals, Inc. · NASDAQ:ELDN

Matthew D. Perry reported a 5.98% stake in Eledon Pharmaceuticals, Inc. (Schedule 13G)

Event Nov 19, 2025 · Filed Nov 24, 2025

Matthew D. Perry reported a 5.98% stake in Eledon Pharmaceuticals, Inc., 4,762,691 shares, as a passive investor on Nov 19, 2025. Filed Nov 24, 2025 (Schedule 13G).

Stake
5.98%
Shares
4,762,691
Intent
Passive
What changed
Crossed above 5%
Filed together
5 holders

The filing in full

HolderStakeShares
Coastlands Capital LP5.28%4,203,764
Coastlands Capital Partners LP5.28%4,203,764
Coastlands Capital GP LLC5.28%4,203,764
Coastlands Capital LLC5.28%4,203,764
Matthew D. Perry5.98%4,762,691

Source

View original at SEC

Related